Mammalian transmissible spongiform encephalopathies are uncommon and irreversible diseases caused by prions. Prions lack nucleic acid and can self-propagate by converting normal cell protein to isomeric prion form. In the pathogenesis of these diseases a long variable incubation period occurs, followed by progressive appearance of severe clinical symptoms and death.
. The protein molecule present in healthy individuals converts to prion protein through an unknown post-translational process and misses any nucleotide determinant other than the normal gene. After initial single conformational change, the resulted altered protein serves as a template for fast, irreversible and fatal propagation of amyloid state. Hence, the deleterious phenotype can be a result either from loss of normal protein function or from toxicity gain due to amyloid formation. 
Ure2p -a yeast nitrogen repression regulator 'of no importance'
A decade before the appearance of 'anti-dogma' protein-only theory, a totally unrelated event occurred in the yeast microbiology. Lacroute had reported the existence of one non-Mendelian genetic element in Saccharomyces cerevisiae, associated with nitrogen metabolism regulation [2, 3] . At that time nobody realized that after twenty years this genetic element would become the major milestone of all prion studies and the strongest proof for protein infectivity.
These early works reported the isolation of recessive (ure2) and dominant (URE3) mutations both determining the ability to overcome the effect of nitrogen catabolite repression (NCR), a regulatory mechanism involved in the cell response to different nitrogen sources. In brief, when S. cerevisiae grows on a preferred nitrogen source, the good nitrogen (ammonia) strongly represses the expression of genes required for the utilization of alternative nitrogen sources (proline or glutamate) (for reviews see [4, 5] ). Depleting of preferred nitrogen source induces high level expression of required genes to ensure the assimilation of less preferred nitrogen sources available in the medium.
While ure2 mutation is recessive and shows ordinary Mendelian inheritence, [URE3] manifests dominant inherit-ance and does not have any known genetic distribution in the offspring. In sporulation experiments it displays a 4/0 segregation -all formed spores are [URE3]. First, as it can be transmitted via cytoduction, it was thought to be part of the mitochondrial genome [2] . However, its behavior is quite different from the inheritance of a mitochondrial or plasmid gene. In addition, [URE3] does not propagate in ure2∆ mutant: the corresponding gene was found to be located in the nucleus of yeast cells and to be identical to that of the recessive mutation ure2 [3] . This strange and very unusual behavior was finally and somewhat surprisingly explained by Wickner in 1994 [6] who extended the prion concept to yeast proteins.
Is Ure2p/[URE3] a real prion?
Wickner has proposed several genetic criteria to identify a protein as a prion [6, 7] . First, there would be a reversible curability: prions, as well viruses and plasmids can be cured or eliminated from the infected cells after some treatment; while other infectious elements cannot appear de novo in the same cell after curing, prions can arise again, as the normal protein is still there. In fact, 5 Human prion protein is a 253 amino acid protein with glycosylphosphatidyl-inositol (GPI) anchor to translocate into the plasma membrane [17] . The yeast protein Ure2p is cytosolic and consists of 354 amino acids divided in two welldefined regions -unstructured, flexible and protease-sensitive N-terminal domain of around 90 amino acids and globular, functional C-domain [18] . The N-terminal domain contains up to 45% polar uncharged amino acids (asparagine and glutamine) (Fig. 2) and suffices for induction of [URE3] phenotype in vivo [9] and for amyloid forming in vitro [11, 19] . Glutamine repeats excess is associated with a number of neurodegenerative diseases, including Huntington's disease [20] , but is not present in human prion protein. Deletion of asparagine/glutamine repeats in the prion domain of Ure2p reduces the prion generation and propagation [21] and inhibits in vitro amyloid formation [19] . The amino acid composition of N-terminal prion region itself and not the exact sequence determines the ability of Ure2p to change in a prion state. Different URE2 variants, each of them with shuffled nucleotides, but unchanged amino acid content and codon use were generated and introduced on the place of normal gene. All of these variants were able to form [URE3] amyloids in vitro [22] .
Tertiary structure of Ure2p -two in one phenomenon
To understand the way prions arise and propagate, we need to know the structure of normal and prion states of the protein. Unfortunately, all traditional approaches (X-ray crystallography and solution NMR) are not applicable in the case of prions, as they could not crystallized because of their filamentous nature. Ure2p was the first prion protein to enlighten the structural issue, because of its combined structure. While N-terminal part of Ure2p molecule is necessary and sufficient for prion properties of Ure2p [9] , the C-terminal part represents the functional part of the molecule and displays a structural similarity to a class of detoxifying enzymes -glutathione S-transferases (GST) [23] . The two regions are not overlapping and have negligible effects each other. This gives an easier approach to understand prion structure -by dividing the molecule to its functionally separated parts and studying each part independently. Thus, the first prion structure (in fact the non-prion region of a prion protein) appeared in 2001 [24, 25] . Recently, solid-state NMR has addressed the atomic-resolution structure of full-length Ure2p to confirm a very well ordered globular domain with a conserved GST fold, and a partially ordered prion domain [26] .
Purification experiments (after overexpression in Escherichia coli cells) demonstrate that recombinant Ure2p is a soluble monomeric protein which can form dimers, tetramers, as well as insoluble high molecular weight fibrillar oligomers able to bind Congo Red as do amyloid fibers [18] .
The finding that shuffling the amino acid sequence of Ure2p prion domain does not destroy its prion capacity [22] let to the proposition that the prion structures are parallel inregister beta-sheets. According to this model, the beta-sheets in the N-terminal end of each molecule aligne with identical residues stacked on top of each other. This forms an amyloid core with globular non-prion domains hanging off the core [reviewed in 27].
The functional diversity of Ure2p -a unique feature
Ure2p (in its normal state) retains a broad spectrum of physiological roles in yeast cell -regulates nitrogen catabolite repression (NCR), salt stress and glutathione (GSH) degradation, and participates in various oxidant and heavy metal detoxifications (Fig. 3) . Ure2p is a regulator in NCR, a mechanism which prevents unnecessary production of permeases and other proteins for the utilisation of non-preferred compounds, when a preferred nitrogen source is available. It is the major negative regulator of GATA family of transcription factors in S. cerevisiae cell [4] . Ure2p binds to two of GATA factors Gln3p and Gat1p preventing their nucleus localization and therefore inhibiting the transcription of GATA regulated genes. In response to external stimuli (for example, nitrogen limitation), Gln3p and Gat1p discharge from Ure2p and enter the nucleus to activate transcription of needed genes (Fig. 3) . Beyond the nitrogen regulation, ure2∆ mutant exhibits a pleiotropic phenotype determined by transcriptional GATA repression of other genes involved in cell response to salt stress [28] and in the degradation of glutathione [29] .
Ure2p completely loses its NCR regulatory function during conformational change in [URE3] prion state [3] and this is likely to be a steric effect rather than loss of native structure.
When the sequence similarity of Ure2p to GSTs [23] Although Ure2p has GPx activity in vitro with inorganic and organic peroxides in both native and prion-aggregated form [31] , as well as glutaredoxin activity [32] , attempts to demonstrate activity of Ure2p with canonical GST model substrates such as 1-chloro-2,4-dinitrobenzene, have been unsuccessful [33] . However, disruption of the URE2 gene renders S. cerevisiae sensitive to possible alternative GST substrates such as Al, Ag, As, Cd, Co, Cr, Cu, Fe, Hg, Ni, Se, diamide, hydrogen peroxide, cumene and t-butyl hydroperoxides [34, 35, 36, 37, 38] . The identification of these new ure2∆ phenotypes prompts the question whether the detoxication of heavy metals and peroxides derives from an enzymatic activity as a GST enzyme, or is a result of direct/indirect GATA regulation of one or more genes whose products are involved in cellular defense against oxidative stress. To solve this question is important as the Ure2p regulatory activity associates with a stoichiometric reaction between a GATA factor and itself. Since Ure2p in its prion form is a fibrillar polymer, it is evident that it cannot keep this interaction. In contrast a GST activity may not be adversely affected by prion formation because this is catalytic rather than stoichiometric reaction.
In fact both possibilities may happen in vivo. Despite the GPx activity in vitro [31] , the disruption ure2∆ mutant displays unchanged GPx activity in vivo. Its inability to grow in presence of hydrogen peroxide is related to diminishing levels of GSH as a result from increased GSH degradation due to deregulated localization of the gamma-glutamyl transpeptidase activating GATA factors [37] . Experimental data rejects a direct enzymatic role of Ure2p in arsenic detoxication [38] . As for peroxides sensitivity, Ure2p is likely to control arsenic transport via GATA regulatory function rather than to conjugate arsenic ions. In contrast, Ure2p seems to participate directly in nickel and cadmium detoxification and [URE3] prion formation does not affect this function [35] .
The well-characterized functional diversity of Ure2p is a unique feature while more of the known mammalian prions are of yet unspecified functions. However, many reports show similar protective role of mammalian prions against oxidative damage and participation in metal metabolism [39] . Prion neurotoxicity in mammals may derive from imbalance of metal homeostasis and oxidative redox state in brain tissues (reviewed in [40] ). Two ways of actions are considered: (1) a functional role in metal metabolism (Cu, Fe, Zn, Mg and Ni) and loss of this function when protein molecules aggregate; and (2) gain of toxic function when metals are included in redox-active aggregates, able to generate oxidative stress. Studies on cell and animal model support in same degree both hypotheses but neither the physiological role of metal binding nor the pathogenicity of metal-prion complexes is elucidated.
The coincidence in anti-oxidative functions of lower and higher eukaryotic prions is a pertinent question deserving more experiments, as it can be in the basis of profound understanding of the role of human prion proteins.
CONCLUSION
Yeast prions including Ure2p provide an excellent model for studying mechanisms of prion formation and propagation. An essential issue is the biological role of prions, which in human yet has to be discovered. Understanding in more details how Ure2p functions and in what conditions it loses the variety of its functions (or only some of them) and becomes infectious will help our understanding of a range of severe neurodegenerative diseases in human.
